Gilder Gagnon Howe & Co. LLC Trims Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Gilder Gagnon Howe & Co. LLC lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 7.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,041,736 shares of the company's stock after selling 80,114 shares during the quarter. Gilder Gagnon Howe & Co. LLC owned 0.61% of Option Care Health worth $24,168,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health in the fourth quarter valued at approximately $26,000. UMB Bank n.a. lifted its holdings in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC lifted its holdings in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC lifted its holdings in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after acquiring an additional 1,099 shares during the period. Finally, Sterling Capital Management LLC lifted its holdings in Option Care Health by 638.5% in the fourth quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock valued at $69,000 after acquiring an additional 2,554 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.

Insider Buying and Selling

In related news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is owned by insiders.

Option Care Health Stock Down 0.9 %

Shares of NASDAQ OPCH traded down $0.29 during midday trading on Thursday, hitting $32.03. The company's stock had a trading volume of 1,273,297 shares, compared to its average volume of 2,009,602. The business's fifty day simple moving average is $33.34 and its two-hundred day simple moving average is $28.82. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The firm has a market capitalization of $5.26 billion, a price-to-earnings ratio of 26.89, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same quarter last year, the firm posted $0.26 earnings per share. The business's revenue for the quarter was up 16.3% compared to the same quarter last year. On average, equities analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Ratings Changes

OPCH has been the subject of several research analyst reports. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research note on Wednesday. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, Option Care Health has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.